Stay updated on Nivolumab in Type B3 Thymoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Type B3 Thymoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Type B3 Thymoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page revision was updated from v3.4.2 to v3.4.3 (the previous v3.4.2 tag was removed).
    Difference
    0.0%
    Check dated 2026-03-11T18:40:14.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 is added, and the previous government-funding maintenance notice and the Revision: v3.4.1 entry have been removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:20:43.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A system notice about a lapse in government funding was added, and the page revision was updated to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T05:34:16.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; Removed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T03:20:11.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision tag updated to v3.3.4; the previous tag v3.3.3 was removed. This is a metadata update and does not alter any study information displayed on the page.
    Difference
    0.0%
    Check dated 2026-01-14T01:22:09.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a site revision note 'Revision: v3.3.3' to the footer and removed the 'HHS Vulnerability Disclosure' link along with the older 'Revision: v3.3.2' reference. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T17:23:18.000Z thumbnail image

Stay in the know with updates to Nivolumab in Type B3 Thymoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Type B3 Thymoma Clinical Trial page.